Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Injection vs. Continuous Adductor Canal Block for TKA
NCT02991404Phase 1Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Feb 2017
- Primary completion
- Nov 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of buprenorphine extended-release injection and dexamethasone in postoperative pain, sponsored by Wake Forest University Health Sciences. Started Feb 2017; status: completed.
02
Drugs
buprenorphine extended-release injectiondexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02991404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02991404.